Table 3 The average dosimetry results of PTV for 20 test patients. Seven dosimetry indexs, \({D}_{99\%}\), \({D}_{98\%}\), \({D}_{95\%}\), \({D}_{50\%}\), \({D}_{2\%}\), HI and CI, are included
Dosimetry indexes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Models | \({\varvec{D}}_{90\varvec{\%}}\) | \({\varvec{D}}_{98\varvec{\%}}\) | \({\varvec{D}}_{95\varvec{\%}}\) | \({\varvec{D}}_{50\varvec{\%}}\) | ||||||||
Predicted | Clinical | P-val | Predicted | Clinical | P-val | Predicted | Clinical | P-val | Predicted | Clinical | P-val | |
Model-A | 53.4 ± 0.8 | 53.3 ± 0.6 | 0.596 | 54.2 ± 0.5 | 54.2 ± 0.4 | 0.449 | 55.1 ± 0.3 | 55.0 ± 0.3 | 0.104 | 57.0 ± 0.3 | 56.9 ± 4.0 | 0.061 |
Model-B | 53.0 ± 0.9 | 0.108 | 54.0 ± 0.4 | 0.025 | 55.0 ± 0.3 | 0.683 | 57.3 ± 0.3 | < 0.001 | ||||
Model-C | 50.6 ± 2.4 | < 0.001 | 52.4 ± 1.7 | < 0.001 | 54.3 ± 1.0 | 0.002 | 57.7 ± 0.3 | < 0.001 | ||||
Dosimetry indexes | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Models | \({\varvec{D}}_{2\varvec{\%}}\) | HI | CI | ||||||
Predicted | Clinical | P-val | Predicted | Clinical | P-val | Predicted | Clinical | P-val | |
Model-A | 59.6 ± 0.7 | 58.5 ± 03 | < 0.001 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.086 | 0.8 ± 0.0 | 0.8 ± 0.0 | 0.071 |
Model-B | 59.6 ± 0.5 | < 0.001 | 54.2 ± 1.4 | 0.073 | 0.8 ± 0.0 | 0.068 | |||
Model-C | 60.0 ± 0.4 | < 0.001 | 54.2 ± 1.4 | < 0.001 | 0.6 ± 0.0 | < 0.001 | |||